Transparent pharmacy benefit manager (PBM) with clinician-led care navigation for employers
Rightway is a New York-based pharmacy benefit manager and care navigation company that sells employers a transparent PBM model: a per-enrollee fee untethered to drug prices, 100% rebate pass-through and a total pharmacy spend guarantee (SureSpend), with pharmacists guiding members to high-value medications. It counts 45 Fortune 500 companies as clients, serves about 3 million people and says it is profitable; Eli Lilly moved its employee plan to Rightway and Mayo Clinic is slated to switch in January. On 2026-09-24 it announced a $155M Series E led by Francisco Partners with Thrive Capital and Khosla Ventures; Bloomberg reported a $1.75B valuation and $281M raised to date. Co-founder and CEO Jordan Feldman says an IPO is being weighed on a roughly four-year horizon.
Healthcare📍 New York, NY
Current Valuation
$1.8B
as of 2026-09-24
UNICORN
QL Price
$1.8B
0% vs last round
QuantLogix's current estimate for Rightway, published 2026-09-25 — in line with the last disclosed round of $1.8B (2026-09-24).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$1.8B
2026-09-24
weight 1
How this price has held up
No round has priced for Rightway since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-25 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Rightway, 2026-09-25 (f7959294955a17a9).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Rightway going public?
No. Rightway is private and has not filed to go public. There is no S-1 on file.
What is Rightway's valuation in 2026?
Rightway is valued at $1.8B as of 09/24/2026, set by its Series E ($155M, Sep 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Rightway filed an S-1?
No public S-1 is on file for Rightway.
Who are Rightway's investors?
Rightway's investors include Francisco Partners, Thrive Capital, Khosla Ventures, Tiger Global Management.
How much has Rightway raised?
Rightway has raised $281M in total across 3 disclosed rounds, most recently a Series E of $155M in Sep 2026.
Is Rightway publicly traded — can you buy Rightway stock?
No. Rightway is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Rightway on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Jordan Feldman
HQ
New York, NY
Total Raised
$281M
Growth
45 Fortune 500 clients; serves about 3 million people; profitable; Mayo Clinic slated to switch in January 2027 (Bloomberg, Sept 2026)
Last Round
Series E — $155M (Sep 2026) · Lead: Francisco Partners
IPO Status
private
Fundraising Status
Series E · $155M · this month
privateTotal raised $281M3 disclosed rounds
Series E Impact
Round Size
$155M
Primary financing announced
Post-Money Valuation
$1.8B
Company-announced mark
Valuation Step-Up
+59.1%
vs Series C at $1.1B
Round / Post-Money
8.9%
New capital ÷ post-money
Disclosed Funding
$281M
Cumulative disclosed rounds
Step-up compares disclosed post-money valuations. Round / post-money is a financing-size ratio, not an ownership or dilution estimate.
Growth & Valuation
Valuation across funding rounds
Capital raised per round
Charts built from publicly disclosed funding rounds and revenue estimates. Approximate, not real-time, not investment advice.
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series E
$155M
Sep 2026
Francisco Partners
$1.8B
Series D (per SEC Form D)
$109M
Mar 2024
—
—
Series C
$100M
Mar 2021
Khosla Ventures
$1.1B
Talent Signal
Hiring data for Rightway has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
Founders & Key People
Jordan Feldman
Investors
Francisco Partners · Thrive Capital · Khosla Ventures · Tiger Global Management
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-09-24. Refreshed quarterly.